Creator: Help Dementia Editorial Team
Published: 2026-04-02T11:26:29

Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.

Top killer sits at the center of this dementia and brain health question.

Dementia is now Australia’s leading cause of death—a watershed moment that arrived in 2024 when dementia deaths for the first time surpassed ischaemic heart disease as the nation’s top killer. With over 17,500 deaths representing 9.4% of all Australian deaths, the rise reflects both a demographic reality and a public health crisis that has been decades in the making. What makes Australia’s experience instructive for Americans is not the crisis itself—the United States faces a similar epidemic, though one that remains officially underrecognized—but rather how Australia has responded. While Americans watch dementia deaths climb 142% since 2000, Australia has launched a comprehensive national strategy with concrete, evidence-based interventions. This article examines why dementia became Australia’s top killer, what that reveals about aging and disease patterns, and the specific policy and prevention approaches that Americans should consider adopting.

The story behind Australia’s dementia milestone is not one of a sudden disease spike, but rather of an aging population intersecting with mortality trends. Between 2015 and 2024, dementia deaths increased by nearly 39%, far outpacing the growth in other leading causes. More than 68% of dementia deaths occurred in people over 75, a cohort that has grown significantly as Australians live longer. Women have been hit particularly hard—62.4% of those who died from dementia in 2024 were women, a pattern that has held since dementia became the leading cause of death for Australian women in 2016. With 433,300 Australians currently living with dementia and projections showing that number nearly doubling to 812,500 by 2054, the nation faced a choice: treat dementia as an inevitable tragedy of aging or build a preventive infrastructure. Australia chose the latter.

How an Aging Population Transformed Dementia Into Australia’s Top Killer
Why the United States Hasn’t Recognized Dementia as Its Top Killer—Yet
Australia’s Comprehensive National Dementia Action Plan and What It Entails
The Multidomain Prevention Model—Evidence From AU-ARROW and International Trials
Why the United States Lacks a Comparable National Strategy
Lessons for the American Healthcare System
The Global Convergence on Dementia Prevention and What It Means for the Coming Decade
Conclusion

How an Aging Population Transformed Dementia Into Australia’s Top Killer

Australia’s ascent to the top of the mortality charts reflects a straightforward epidemiological fact: as populations age and other major causes of death decline, dementia emerges. However, the story is more nuanced than simple aging. The 39% increase in dementia deaths over a single decade suggests that while aging is the baseline, something else is shifting. Part of the answer lies in improved diagnosis and death certification—better recognition of dementia as the primary cause rather than a contributing factor. But another part reflects genuine increases in prevalence, driven not only by the aging of the Baby Boomer generation but by the fact that Australians are living longer with dementia, moving through earlier stages that were once missed entirely. The gender disparity is particularly striking. Women accounting for 62.4% of dementia deaths is not accidental. Women live longer than men on average, and dementia risk increases exponentially with age.

For women over 85, dementia becomes increasingly prevalent. Australia’s data also shows that dementia has been the leading cause of death for women since 2016—six years before it became the nation’s leading cause of death overall. This suggests a critical intervention point: understanding why women are disproportionately affected and how health systems can better serve them. However, the rising prevalence of dementia in women should not overshadow the reality that men are diagnosed with dementia at higher rates in younger age groups, indicating that prevention strategies must account for both the prevalence patterns and the sex differences in disease progression. The demographic shift tells another part of the story. In 2024, more than 68.2% of all deaths involved people aged over 75, compared to 63.3% two decades earlier. This aging of the deceased population means that conditions like dementia, which strike hardest in advanced age, inevitably become more common causes of death. Yet this demographic inevitability does not excuse inaction. Rather, it clarifies the timeline: Australia has a closing window to implement prevention strategies before the oldest Baby Boomers move fully into the high-risk age brackets of 85 and above.

How an Aging Population Transformed Dementia Into Australia's Top Killer

Why the United States Hasn’t Recognized Dementia as Its Top Killer—Yet

In the United States, Alzheimer’s disease remains the 6th or 7th leading cause of death, far below the top spot where Australia’s dementia has claimed the crown. The official statistics are sobering enough: 120,122 deaths from Alzheimer’s in 2022, with 7.2 million Americans aged 65 and older currently living with Alzheimer’s dementia. Yet these figures severely underestimate the true burden. Research from Rush University and other institutions suggests that Alzheimer’s may be an underlying cause in five to six times as many deaths as officially reported—a discrepancy that would place the real death toll between 600,000 and 720,000 annually, easily surpassing heart disease and cancer. The gap between official US dementia deaths and Australia’s reflects several factors. The United States has a different age structure than Australia, with a slightly younger population overall, though this advantage is narrowing as the Baby Boom generation ages. More significantly, the US healthcare system fragments responsibility for dementia diagnosis and reporting across thousands of independent providers, leading to inconsistent coding and underreporting.

When an elderly person with dementia dies from pneumonia or heart failure, the dementia is often treated as a secondary condition rather than the primary cause—particularly if the person was living in a nursing facility that prioritizes acute illness reporting. Australia’s more centralized health system has created infrastructure for more consistent death certification. Additionally, the US has not yet developed the comprehensive national dementia strategy that Australia launched, meaning there is no coordinated national focus on recognizing and documenting dementia’s true impact. This underrecognition has consequences. If Americans do not fully grasp dementia’s true mortality burden, they will not demand the prevention resources that evidence suggests could avert hundreds of thousands of deaths. However, the gap between official and actual deaths also represents opportunity: the US has been making progress in dementia prevention research without yet recognizing how urgent the problem truly is. The infrastructure for change—large clinical trials, growing specialist networks, and increasing public awareness—already exists. What is missing is the national narrative shift that Australia experienced when dementia officially became the nation’s top killer.

Australia’s Comprehensive National Dementia Action Plan and What It Entails

In response to rising dementia deaths and the forecast that prevalence would nearly double by mid-century, Australia did not issue warnings or allocate hospital beds. Instead, it launched the National Dementia Action Plan 2024–2034, an eight-point strategic framework designed to prevent, detect, and manage dementia across the population. The plan represents one of the first comprehensive dementia-specific policy frameworks established at a national level, coordinating action across the federal government and state and territory authorities—a coordinated approach that the fragmented US system has not yet attempted. The National Dementia Action Plan is built on a multidomain prevention model, focusing on the lifestyle and health factors most strongly associated with dementia risk reduction. These include physical activity, nutritional guidance, cognitive and social engagement, medical monitoring for vascular risk factors, and health education. Rather than betting on a single intervention or a future pharmaceutical breakthrough, Australia’s approach hedges its bets across multiple lifestyle domains simultaneously.

The plan is supplemented by ten additional strategies aimed at improving social policies and creating incentives for physical activity and healthy brain aging. This means governments are not only telling people what to do; they are structuring communities, healthcare systems, and incentive schemes to make the healthy choice the easy choice. The Australian Institute of Health and Welfare developed an online dashboard to track implementation progress annually, embedding accountability into the system. This transparency mechanism is critical: it means that if certain interventions are not working as hoped, or if some regions are lagging, decision-makers have real-time data to course-correct. The plan is also aligned with international research efforts, most notably through the AU-ARROW clinical trial, which tests multidomain intervention to prevent or delay cognitive impairment in older adults at risk. This trial is coordinated internationally through the World-Wide FINGERS initiative, meaning Australia is both conducting its own research and contributing to global knowledge. However, a limitation of Australia’s plan is that it relies heavily on voluntary adoption of lifestyle changes by individuals—understanding what works at the population level is different from getting millions of people to consistently exercise, eat well, and engage cognitively.

Australia's Comprehensive National Dementia Action Plan and What It Entails

The Multidomain Prevention Model—Evidence From AU-ARROW and International Trials

The AU-ARROW trial and the parallel US POINTER trial represent the cutting edge of dementia prevention research. Unlike past approaches that focused on a single intervention—say, cognitive training or exercise alone—multidomain interventions simultaneously target multiple risk factors. The model is straightforward in concept but demanding in execution: participants receive physical activity counseling, nutritional guidance, vascular risk factor management (blood pressure, cholesterol, glucose control), cognitive training, and psychosocial stress reduction, all coordinated by a multidisciplinary team. The evidence supporting this approach is strong. Research has identified that lifestyle interventions combining exercise, healthy diet, vascular risk management, and stress reduction show the most promise for delaying or preventing cognitive decline. Physical activity alone improves brain health, but it works better in combination with nutritional optimization. Cognitive training alone shows modest benefits, but paired with social engagement and cardiovascular health improvements, the effect is greater.

This synergy is why Australia pivoted toward multidomain interventions rather than putting all resources into a single intervention. The AU-ARROW trial specifically targets older adults already at risk—those with baseline cognitive impairment or cognitive concerns—recognizing that prevention is most effective when applied to those most likely to decline. One important caveat is that multidomain interventions are resource-intensive and require sustained engagement. They cannot be delivered as a pill or a one-time procedure. They demand that participants commit to changing multiple aspects of their lives simultaneously, which is why the Australian approach also emphasizes systemic change—building environments and policies that support these behaviors rather than relying solely on individual willpower. A person living in a neighborhood without sidewalks, near few social venues, and in a community without affordable healthy food faces a very different barrier than someone with access to parks, senior centers, and produce markets. Australia’s plan acknowledges this by pairing individual interventions with population-level structural changes.

Why the United States Lacks a Comparable National Strategy

The United States has not established a comprehensive national dementia action plan equivalent to Australia’s. The reasons are partly structural and partly political. The US healthcare system is highly decentralized, with Medicare, Medicaid, and private insurance each operating according to different rules and incentives. This fragmentation makes it difficult to implement coordinated, population-level strategies. Moreover, the US does not have a federal health service comparable to Australia’s Medicare system, meaning that a national plan would have to coordinate action across multiple payers, hospitals, and providers with no single entity in charge. Political attention to dementia in the United States has historically been far lower than attention to cancer, heart disease, or Alzheimer’s specifically. Even the Alzheimer’s Association, the major advocacy organization, has not articulated a comprehensive prevention framework at the national level. Instead, prevention research proceeds through NIH-funded trials and private foundations, generating excellent science but no unified national response.

The US National Plan to Address Alzheimer’s Disease exists but focuses primarily on research funding and care infrastructure rather than prevention at a population level. Additionally, the US healthcare system is structured around acute care and treatment of diagnosed disease, not prevention. Incentive structures reward treating dementia once it occurs, not preventing it beforehand. Doctors have little reimbursement for counseling patients about exercise or diet, and payers have little incentive to invest in prevention that may only pay off decades in the future. A critical limitation of the US approach is that prevention research, while robust, does not translate automatically into public health action. The POINTER trial and similar studies generate evidence, but without a national framework to disseminate and implement findings, the evidence sits in medical journals. Australia’s advantage is not that its scientists are more skilled—US researchers are at the forefront of dementia prevention science—but that Australia has created institutional structures to turn evidence into population-level practice. The US will need comparable structures, likely beginning with a federal commitment to dementia prevention comparable to its historical commitments to cancer or heart disease.

Why the United States Lacks a Comparable National Strategy

Lessons for the American Healthcare System

What Americans can learn from Australia’s approach is threefold: first, the importance of naming the problem clearly. When dementia became Australia’s leading cause of death in official statistics, it became impossible to ignore. The US would benefit from fuller recognition of dementia’s true mortality burden and from consistent death certification that accurately reflects dementia’s role. This is not merely academic; it drives attention and resources. Second, Americans can learn from Australia’s multidomain prevention model embedded in a coordinated national framework.

The US already has strong research showing that exercise, cognitive engagement, social connection, and cardiovascular health optimization reduce dementia risk. What is missing is a structured approach to implementing these interventions at scale, coordinating across healthcare providers, public health agencies, and community organizations. Australia’s approach suggests that prevention is most effective when it targets not isolated individuals but entire populations, restructuring communities and incentive systems to support brain health. Third, Australia demonstrates the value of transparency and accountability. The annual progress dashboard may seem like a small thing, but it embeds the assumption that implementation matters as much as policy design. The US government could establish similar tracking mechanisms, creating visibility into whether dementia prevention initiatives are actually reaching people and changing outcomes.

The Global Convergence on Dementia Prevention and What It Means for the Coming Decade

The AU-ARROW trial is not isolated; it is part of a global movement toward dementia prevention through the World-Wide FINGERS initiative, which is coordinating prevention trials across dozens of countries. This international convergence suggests that within the next five to ten years, the evidence base for dementia prevention will be far more robust than it is today. As evidence accumulates, the case for national implementation strategies will strengthen. Australia is positioned to be a leader in translating evidence into practice. The US, with its larger population and greater resources, could do the same—but only if it commits to a comparable strategic framework. The coming decade will also see the oldest Baby Boomers entering the age of highest dementia risk, 85 and older.

Both Australia and the United States will face rapidly rising dementia incidence unless prevention efforts are scaled dramatically. Australia’s national plan is an attempt to address this demographic wave proactively. The US is not yet making a comparable effort at the national level, though individual healthcare systems and states are experimenting with prevention programs. The outcome for both nations will depend on whether prevention research is transformed into sustained, large-scale practice. Australia’s advantage is institutional; the US’s advantage is in research capacity and resources. The question for the coming decade is whether the US will develop the institutional will to match its research capability.

Conclusion

Australia’s ascent of dementia to the leading cause of death is both a warning and a lesson. The warning is that as populations age globally, dementia will become an increasingly dominant cause of mortality and morbidity unless prevention strategies are dramatically scaled. The lesson is that comprehensive, multidomain, population-level prevention coordinated through national strategy is feasible and is grounded in evidence. While the United States has long been aware of dementia as a public health problem and has funded excellent research, it has not yet created the institutional and policy frameworks to implement prevention at the scale needed to change population outcomes. Australia’s National Dementia Action Plan, multidomain prevention approach, and coordinated national strategy offer a template. The ingredients for success exist in the United States—evidence-based interventions, willing researchers, and growing public concern about dementia.

What is required is the political and institutional commitment to align those ingredients into a coherent national response. Americans concerned about dementia should not wait for that national commitment to materialize. The evidence supporting multidomain prevention is strong enough to act on now. Engaging in regular physical activity, maintaining cognitive and social engagement, optimizing diet and cardiovascular health, and managing stress are not speculative interventions—they are among the most evidence-supported actions available to reduce dementia risk. For individuals and healthcare providers, the path forward is clear. For policymakers, the question is whether the United States will learn from Australia’s experience and build a comprehensive national framework, or whether it will continue to address dementia through fragmented approaches that have not yet altered the trajectory of the crisis.